DD128590A5 - Verfahren zur herstellung optisch aktiver 11-desoxy-16-aryl-omega-tetranorprostaglandine - Google Patents
Verfahren zur herstellung optisch aktiver 11-desoxy-16-aryl-omega-tetranorprostaglandineInfo
- Publication number
- DD128590A5 DD128590A5 DD7600195365A DD19536576A DD128590A5 DD 128590 A5 DD128590 A5 DD 128590A5 DD 7600195365 A DD7600195365 A DD 7600195365A DD 19536576 A DD19536576 A DD 19536576A DD 128590 A5 DD128590 A5 DD 128590A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- tetranorprostaglandine
- opticallely
- desoxy
- omega
- aryl
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/624,486 US3984400A (en) | 1975-10-21 | 1975-10-21 | 11-Desoxy-16-aryl-ω-tetranorprostaglandins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD128590A5 true DD128590A5 (de) | 1977-11-30 |
Family
ID=24502191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD7600195365A DD128590A5 (de) | 1975-10-21 | 1976-10-20 | Verfahren zur herstellung optisch aktiver 11-desoxy-16-aryl-omega-tetranorprostaglandine |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US3984400A (ja) |
| JP (2) | JPS5251353A (ja) |
| AR (1) | AR213831A1 (ja) |
| AT (1) | AT360673B (ja) |
| BE (1) | BE847447A (ja) |
| BG (1) | BG31070A3 (ja) |
| CA (1) | CA1092103A (ja) |
| CH (1) | CH619930A5 (ja) |
| CS (2) | CS191321B2 (ja) |
| DD (1) | DD128590A5 (ja) |
| DE (1) | DE2646878A1 (ja) |
| DK (1) | DK472976A (ja) |
| ES (1) | ES452538A1 (ja) |
| FI (1) | FI762990A (ja) |
| GB (1) | GB1520958A (ja) |
| GR (1) | GR63621B (ja) |
| HU (1) | HU175022B (ja) |
| IE (1) | IE44016B1 (ja) |
| IL (1) | IL50657A (ja) |
| LU (1) | LU76045A1 (ja) |
| NL (1) | NL163780C (ja) |
| NO (1) | NO763451L (ja) |
| NZ (1) | NZ182297A (ja) |
| PH (1) | PH11472A (ja) |
| PL (1) | PL112539B1 (ja) |
| PT (1) | PT65727B (ja) |
| RO (1) | RO71900A (ja) |
| SE (1) | SE7610995L (ja) |
| SU (2) | SU727139A3 (ja) |
| ZA (1) | ZA766204B (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4365077A (en) * | 1975-06-23 | 1982-12-21 | Pfizer Inc. | 11-Desoxy-16-aryloxy-ω-tetranorprostaglandins |
| ZA77160B (en) * | 1976-02-13 | 1977-11-30 | Upjohn Co | Prostaglandin analogs |
| US4140721A (en) * | 1976-07-26 | 1979-02-20 | The Upjohn Company | 2-Decarboxy-2-hydroxymethyl-13,14-didehydro-17-phenyl-PGA, PGD and PGE compounds |
| US4058564A (en) * | 1976-07-26 | 1977-11-15 | The Upjohn Company | Aliphatic 2-decarboxy-2-hydroxymethyl-13,14-didehydro-PG compounds |
| US4177346A (en) * | 1976-08-06 | 1979-12-04 | Pfizer Inc. | 1,5-Disubstituted-2-pyrrolidones |
| JPS6210843Y2 (ja) * | 1981-01-23 | 1987-03-14 | ||
| JPS59190734U (ja) * | 1983-06-06 | 1984-12-18 | 庄田商事株式会社 | 薄板用連続送り装置 |
| US4576962A (en) * | 1983-10-19 | 1986-03-18 | The Procter & Gamble Company | Prostaglandin analogues |
| US4883614A (en) * | 1984-07-27 | 1989-11-28 | Hoffman-La Roche Inc. | Phenyl substituted-2,4,6,8-nonatetraenoic acid |
| US4780251A (en) * | 1984-07-27 | 1988-10-25 | Hoffman-La Roche Inc. | Phenyl substituted-2,4,6,8-nonatetraenoic acid |
| WO2013024051A1 (en) | 2011-08-12 | 2013-02-21 | Ascendis Pharma A/S | Sustained release composition of prostacyclin |
| US10544915B2 (en) * | 2017-04-27 | 2020-01-28 | Valeo North America, Inc. | Vehicle lamp assembly having an improved heat sink with light shield |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3840573A (en) * | 1970-12-21 | 1974-10-08 | Searle & Co | 2-(3-hydroxy-3-optionally alkylated-1-alkynyl)-3-hydroxy-5-oxygenated cyclopent-1-enealkanoic acids,optical isomers thereof and esters corresponding |
| US3932389A (en) * | 1974-12-11 | 1976-01-13 | Pfizer Inc. | 2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins |
-
1975
- 1975-10-21 US US05/624,486 patent/US3984400A/en not_active Expired - Lifetime
-
1976
- 1976-07-30 IE IE1703/76A patent/IE44016B1/en unknown
- 1976-10-04 SE SE7610995A patent/SE7610995L/xx unknown
- 1976-10-08 NO NO763451A patent/NO763451L/no unknown
- 1976-10-08 GR GR51887A patent/GR63621B/el unknown
- 1976-10-11 NZ NZ182297A patent/NZ182297A/xx unknown
- 1976-10-11 IL IL50657A patent/IL50657A/xx unknown
- 1976-10-12 CA CA263,138A patent/CA1092103A/en not_active Expired
- 1976-10-13 GB GB42614/76A patent/GB1520958A/en not_active Expired
- 1976-10-14 PH PH19004A patent/PH11472A/en unknown
- 1976-10-16 DE DE19762646878 patent/DE2646878A1/de not_active Withdrawn
- 1976-10-18 ZA ZA766204A patent/ZA766204B/xx unknown
- 1976-10-18 CS CS766713A patent/CS191321B2/cs unknown
- 1976-10-18 CS CS775880A patent/CS191343B2/cs unknown
- 1976-10-19 PT PT65727A patent/PT65727B/pt unknown
- 1976-10-20 HU HU76PI549A patent/HU175022B/hu unknown
- 1976-10-20 DD DD7600195365A patent/DD128590A5/xx unknown
- 1976-10-20 BE BE1007708A patent/BE847447A/xx unknown
- 1976-10-20 DK DK472976A patent/DK472976A/da unknown
- 1976-10-20 ES ES452538A patent/ES452538A1/es not_active Expired
- 1976-10-20 FI FI762990A patent/FI762990A/fi not_active Application Discontinuation
- 1976-10-21 SU SU762414464A patent/SU727139A3/ru active
- 1976-10-21 AR AR265178A patent/AR213831A1/es active
- 1976-10-21 CH CH1331676A patent/CH619930A5/fr not_active IP Right Cessation
- 1976-10-21 JP JP51126771A patent/JPS5251353A/ja active Pending
- 1976-10-21 PL PL1976193183A patent/PL112539B1/pl unknown
- 1976-10-21 AT AT785876A patent/AT360673B/de active
- 1976-10-21 LU LU76045A patent/LU76045A1/xx unknown
- 1976-10-21 NL NL7611660.A patent/NL163780C/xx not_active IP Right Cessation
- 1976-10-21 RO RO7688159A patent/RO71900A/ro unknown
- 1976-10-21 BG BG034499A patent/BG31070A3/xx unknown
-
1977
- 1977-07-14 SU SU772502098A patent/SU900806A3/ru active
-
1978
- 1978-11-20 JP JP14323078A patent/JPS5490168A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD130857A5 (de) | Verfahren zur herstellung von n-phosphonomethylglycintriestern | |
| DD132488A5 (de) | Verfahren zur herstellung von reinem methyl-tertiaer-butylaether | |
| AT354447B (de) | Verfahren zur herstellung von indolderivaten | |
| DD129103A5 (de) | Verfahren zur herstellung von n-phosphonomethylglycin | |
| DD128681A5 (de) | Verfahren zur herstellung von n hoch 2-arylsulfonyl-l-argininamiden | |
| DD129330A5 (de) | Verfahren zur herstellung von antitumorsubstanzen | |
| DD128782A5 (de) | Verfahren zur herstellung von n-alkyldiphenylaminen | |
| DD131858A5 (de) | Verfahren zur herstellung von 3-chlorcephemverbindungen | |
| DD130036A5 (de) | Verfahren zur herstellung von optisch aktiven 11-desoxy-16-aryloxy-omega-tetranorprostaglandinen | |
| AT344147B (de) | Verfahren zur herstellung von acylcyaniden | |
| DD128590A5 (de) | Verfahren zur herstellung optisch aktiver 11-desoxy-16-aryl-omega-tetranorprostaglandine | |
| ATA314576A (de) | Verfahren zur herstellung von 4-nideralkyl-5- cyano-oxazolen | |
| DD129326A5 (de) | Verfahren zur herstellung von 1,4-diphenyl-3-pyrazolin-5-onen | |
| DD131556A5 (de) | Verfahren zur herstellung von 5-m-tolyoxyuracil | |
| AT349032B (de) | Verfahren zur herstellung von 4-alkyl-thiosemicarbaziden | |
| DD132435A5 (de) | Verfahren zur herstellung von indolochinolizinen | |
| DD131562A5 (de) | Verfahren zur herstellung von 5-pregnen-derivaten | |
| AT355725B (de) | Verfahren zur herstellung stabiler loesungen | |
| DD122961A5 (de) | Verfahren zur herstellung von diphenylaether-derivaten | |
| DD132431A5 (de) | Verfahren zur herstellung von aryloxy-1-amino-3-propanolen-2 | |
| AT346280B (de) | Verfahren zur herstellung von metaboratloesungen | |
| DD136837A5 (de) | Verfahren zur herstellung pharmazeutisch wirksamer pteridin-verbindungen | |
| ATA505976A (de) | Verfahren zur herstellung des 5-cyan-4-metyl- oxazols(1,3) | |
| DD131088A5 (de) | Verfahren zur herstellung von diaminoalkoxybenzolen | |
| DD128709A5 (de) | Verfahren zur herstellung von dekahydrochinolinderivaten |